3:10–3:30 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Patient and Parent Experiences of Cancer Symptoms as Assessed by the Memorial Symptom Assessment Scale for Children (231-3)

Treatment for childhood cancer is associated with symptoms that contribute to poorer psychological and physical functioning and decreased quality of life. Symptom assessment scales have been used to identify the prevalence, severity, and distress related to cancer treatment.

Read more...
Speaker:
Melody Hellsten, DNP APRN PPCNP-BC CHPPN
CNE Hours
0.34
2:30 – 3:30 pm Friday, September 4

This is Awkward...  Having Difficult Conversations about AYA Sexual Health (227)

Sexual and reproductive health (SRH) is a key aspect of physical health, emotional health, and quality of life in adolescents and young adults (AYAs) with cancer and blood disorders both during and after treatment. AYAs increasingly identify concerns with sexual function, contraception, fertility, and psychosexual adjustment and report conversations on these topics rarely take place with providers.

Read more...
Speaker:
Stacy Whiteside, MS APRN CPON® CPNP-AC/PC
CNE Hours
1
12:15 – 1:15 pm Friday, September 4

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Read more...
Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1
2:30 – 3:30 pm Thursday, September 3

Neurofibromatosis type 1 Diagnostic Updates and Plexiform Neurofibroma Treatment Options (218)

Neurofibromatosis (NF) 1 is a progressive autosomal dominant disorder that results from a germline mutation of a protein called neurofibromin that occurs in one out of every 3500 births (AANS, 2019). The clinical diagnosis of NF1 is based on the presence of two or more cardinal symptoms identified in the 1988 National Institute of Health (NIH) Diagnostic Criteria.

Read more...
Speaker:
Racheal Bingham, MSN CPNP CPON®
CNE Hours
1
12:15 – 1:15 pm Thursday, September 3

Endocrinopathies Related to Cancer Therapy (211)

Due to the remarkable improvements in the care of childhood cancer patients, the 5-year survival rate now exceeds 80%. Long-term survivors of childhood and adolescent cancers may experience a range of adverse outcomes that occur due to treatment-specific factors including chemotherapy and radiation therapy.

Read more...
Speaker:
Angela Yarbrough, DNP APRN FNP-BC CPHON®
Carlee Leopard, MSN CPNP-PC
CNE Hours
1
3:30 – 4:30 pm Wednesday, September 2

Solid and CNS Tumors at Relapse: Creativity and Challenges for the APN (206)

Advanced practice providers are consistently challenged to help provide and deliver new and innovative therapies at the time of relapse. Solid and central nervous system tumors rarely have well-proven, successful treatments at the time of relapse or progression on therapy.

Read more...
Speaker:
Molly Hemenway, DNP MS AC/PC-CPNP
Suzanne Smolik, MSN RN CPNP CPON®
Phyli Forsberg, MSN RN PNP
CNE Hours
1
11:15 – 11:45 am Wednesday, September 2

Rolling the DICER1 (201-2)

Are multiple malignancies in one patient just bad luck? Do different malignancies within the same family signal a cancer predisposition syndrome? Understanding of the human genome demonstrates that many cancers are more than just a bad roll of genetic dice. Benign and malignant conditions that are not seemingly related may be the result of one abhorrent gene.

Read more...
Speaker:
Shelly McQuaid, MS CGC
Barbara Lockart, DNP APRN AC/PC CPHON®
CNE Hours
0.5
Subscribe to this RSS feed